BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6724169)

  • 1. Decreased lysophospholipase and increased phospholipase A2 activity in ileal mucosa from patients with Crohn's disease.
    Bolin T; Heuman R; Sjödahl R; Tagesson C
    Digestion; 1984; 29(1):55-9. PubMed ID: 6724169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease.
    Olaison G; Sjödahl R; Tagesson C
    Digestion; 1988; 41(3):136-41. PubMed ID: 3224765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in permeability and phospholipase A2 activity of colonic mucosa in Crohn's colitis.
    Olaison G; Leandersson P; Sjödahl R; Tagesson C
    Digestion; 1989; 43(4):228-33. PubMed ID: 2612746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation.
    Otamiri T; Franzén L; Lindmark D; Tagesson C
    Gut; 1987 Nov; 28(11):1445-53. PubMed ID: 3428670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of anastomotic recurrence of Crohn's disease after ileocolic resection. Onset proximal to the junction and preceded by increased phospholipase A2 activity.
    Smedh K; Olaison G; Sjödahl R
    Scand J Gastroenterol; 1992 Aug; 27(8):691-4. PubMed ID: 1439552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of group II phospholipase A2 in intestine in Crohn's disease.
    Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Nevalainen TJ
    Am J Gastroenterol; 1999 Mar; 94(3):713-20. PubMed ID: 10086656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.
    Lilja I; Smedh K; Olaison G; Sjödahl R; Tagesson C; Gustafson-Svärd C
    Gut; 1995 Sep; 37(3):380-5. PubMed ID: 7590434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease.
    Haapamäki MM; Grönroos JM; Nurmi H; Söderlund K; Peuravuori H; Alanen K; Nevalainen TJ
    Clin Chem Lab Med; 1998 Oct; 36(10):751-5. PubMed ID: 9853800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intestinal villus phospholipase A2/lysophospholipase bound pancreatic carboxylester lipase?
    Mizuno NK; Brockman HL
    Lipids; 1990 Nov; 25(11):760-2. PubMed ID: 2280682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
    Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of a novel phospholipase B (phospholipase A2--lysophospholipase) from intestinal brush-border membranes.
    Pind S; Kuksis A
    Biochem Cell Biol; 1991; 69(5-6):346-57. PubMed ID: 1716922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular fractionation of human intestinal mucosa by large-scale zonal centrifugation. Localization of the lysophospholipase activity in distal ileum.
    Bolin T; Magnusson KE; Sjödahl R; Tagesson C
    Scand J Gastroenterol; 1982 Nov; 17(8):1057-64. PubMed ID: 6300988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus.
    Testa J; Daniel LW; Kreger AS
    Infect Immun; 1984 Aug; 45(2):458-63. PubMed ID: 6746100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the phospholipase A2 activity of rat ileal mucosa.
    Tagesson C; Sjödahl R
    Scand J Gastroenterol; 1985 Jan; 20(1):25-30. PubMed ID: 3887549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of phospholipase A2 and lysophospholipase in a gastric H,K-ATPase-containing membrane fraction, and the formation of lysophosphatidylcholine in stimulated pig parietal cells.
    Olaisson H; Arvidson G; Ma JY; Mårdh S
    Acta Physiol Scand; 1990 Nov; 140(3):383-92. PubMed ID: 1964531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn's disease.
    Arvanitakis C
    Digestion; 1979; 19(4):259-66. PubMed ID: 478207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease.
    Kald B; Smedh K; Olaison G; Sjödahl R; Tagesson C
    Digestion; 1996; 57(6):472-7. PubMed ID: 8913710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brush border enzyme activities in relation to histological lesion in pediatric celiac disease.
    Prasad KK; Thapa BR; Nain CK; Sharma AK; Singh K
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e348-52. PubMed ID: 18070009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and assay of phospholipase A2 activity from rat jejunal brush-border membranes.
    Pind S; Kuksis A
    Biochim Biophys Acta; 1988 Feb; 938(2):211-21. PubMed ID: 3342232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Entamoeba histolytica intracellular phospholipase A and lysophospholipase L1 activities.
    Vargas-Villarreal J; Martínez-Rodríguez H; Castro-Garza J; Mata-Cárdenas BD; González-Garza MT; Said-Fernández S
    Parasitol Res; 1995; 81(4):320-3. PubMed ID: 7624291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.